Another driver propelling the market throughout the projection period is the growing application area of the DTC testing kits.
Wilmington, Delaware, United States, Oct. 17, 2023 (GLOBE NEWSWIRE) — Transparency Market Research Inc. – The global consumer genomics market was estimated to have acquired US$ 2.4 billion in 2021. It is anticipated to register a 22.3% CAGR from 2022 to 2032 and by 2032, the market is likely to gain US$ 21.2 billion.
Over the course of the forecast period, the market is expected to rise due to rising demand for personalized genomics and increasing accessibility to DTC services as a result of falling genotyping rates. In addition, growing physician and consumer interest in DTC kits together with increasing corporate investment into consumer genomics are anticipated to propel market expansion.
Stricter regulations around the use of DTC genetic testing, growing ethical and clinical concerns about personalized therapy and DTC products, and the lack of uptake of home-based genetic tests because of unclear results are anticipated to impede market expansion.
Download PDF Brochure: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=70491
Key Findings of the Market Report
- Patients and doctors to find family connections and learn more about their ancestry are using genealogy services.
- The consumer gene testing companies are launching deliberate campaigns to increase consumer knowledge of genealogical testing. One of the main uses of consumer genomics, genealogy testing, has finally emerged to pique the interest of both customers and physicians.
- Consumer genomics is being used more frequently because of the growing popularity of genealogy testing.
Market Trends for Consumer Genomics Market
- Participants within the genomics market might have a multitude of opportunities due to the predicted growth of the personalized medicine business. Research on personalized medicine is receiving increased funding from a number of pharmaceutical companies.
- With the use of personalized medicine, medical professionals may determine the precise needs of their patients and recommend treatments and medications accordingly.
- Better care for patients is ensured by this procedure. It is anticipated that developments in gene therapy would supersede conventional drugs and procedures by enabling medical professionals to treat a patient’s condition by introducing a gene into their cell.
- Businesses in the genomics area will have a wealth of opportunities due to the growing personalized medicine market. Numerous pharmaceutical companies are increasing the amount of money they put in research on personalized medicine.
Market for Consumer Genomics: Regional Outlook
Various reasons are propelling the growth of the consumer genomics market in different regions. These are:
- North America accounted for a significant portion of the global consumer genomics market in 2021. The increase of government initiatives supporting precision medicine is responsible for the market growth in the region.
- The adoption of diverse approaches by prominent players to furnish efficacious genomics solutions is propelling the regional market growth throughout the anticipated duration. Due to the entry of new competitors, the retail genomics market in the Asia Pacific is anticipated to grow throughout the projected period.
- The market will gain from expanding understanding of personalized medicine, enhanced lifestyle through retail genomics, and increased funding for research and development.
Enquiry Before Buying @ https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=70491
Global Consumer Genomics Market: Key Players
Leading industry participants have implemented tactical approaches to boost their market share via mergers and acquisitions, product introductions, and other tactics. They are introducing Next Generation Sequencing (NGS)-based programs.
The following companies are well-known participants in the global consumer genomics market:
- 23andMe
- Color Genomics
- Counsyl
- Gene by Gene
- Laboratory Corporation of America
- MyMedLab
- Mapmygenome India
- Positive Biosciences
Key developments in the global market are:
| Company | Year | Key Developments |
| 23andMe | 2020 |
|
| Color Genomics | 2021 |
|
Global Consumer Genomics Market Segmentation
By Application
- Genetic Relatedness
- Diagnostics
- Lifestyle, Wellness, and Nutrition
- Ancestry
- Reproductive Health
- Personalized Medicine & Pharmacogenetic Testing
- Sports Nutrition and Health
- Other Applications
By Region
- North America
- Latin America
- Europe
- APAC
- Middle East & Africa
Place an Order Copy of Consumer Genomics Market Report at: https://www.transparencymarketresearch.com/checkout.php?rep_id=70491<ype=S
About Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact
Nikhil Sawlani
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Blog: https://tmrblog.com
Email: sales@transparencymarketresearch.com
- ECG INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Everus Construction Group, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - May 11, 2025
- CGC INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Canopy Growth Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - May 11, 2025
- Optimove Launches Engage to End “Content Chaos” in the GenAI Age - May 11, 2025
